• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A major step towards individualized cancer therapy

Bioengineer by Bioengineer
June 4, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Izumi Mindy Takamiya

Fuyuhiko Tamanoi of Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in the US succeeded in establishing a versatile, powerful and convenient model to analyse human cancer.

They developed a 'chicken egg tumour model' in which cultured ovarian cancer cells are transplanted on top of the membrane that surrounds a 10-day-old chicken embryo. An ovarian tumour forms on top of the membrane within three days of transplantation.

The team had similar results when they used ovarian tumour samples taken directly from patients, showing that their chicken egg model provides a convenient system for replicating human cancer. This conclusion is supported by their detailed characterization of the tumour, demonstrating that it possesses all major cancer features. "We were surprised when the tumour was formed in three days," says Tamanoi. " This is very rapid considering that it takes weeks to do the same with mice. We can start using this model to test for anti-cancer drugs tailored to each cancer patient's needs. The process can be completed within one week," he says. This is a major step toward individualized medicine for cancer patients.

Tamanoi's team, in collaboration with colleagues in France and Saudi Arabia, also developed a new type of biodegradable silica nanoparticle called 'biodegradable PMO', which is only 200 nanometres in size. The nanoparticles were loaded with the anti-cancer drug doxorubicin and were tested on human ovarian tumour established in the chicken egg.

The biodegradable PMO carrying doxorubicin quickly eliminated the human ovarian tumours without affecting other organs in the chicken embryo. When a smaller amount of the drug, not enveloped in the nanoparticles, was injected in the egg, severe organ damage ensued. This indicates that the team's nanoparticles prevent anti-cancer drug side effects due to their ability to directly target the tumour.

The chicken egg model has several advantages over existing models, such as mouse models, for testing anti-cancer therapies. The tumours form much more rapidly on the chicken embryonic membranes than in mice due to the rich nutrient environment and the incomplete immune system at this stage of embryonic development. Fertilized chicken eggs are also less expensive to use than immune-compromised mice making the model suitable for high throughput experiments.

###

For more information about this research, contact

Fuyuhiko Tamanoi
[email protected]

DOI: 10.1038/s41598-018-25573-8

About Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS)

At iCeMS, our mission is to explore the secrets of life by creating compounds to control cells, and further down the road to create life-inspired super materials that confront the myriad problems that afflict modern society. In only a decade, collaborative research at iCeMS has resulted in significant cutting-edge scientific discoveries, and the creation of over 1500 unique materials. We will keep turning our inspirations into purposeful, transformative innovations for the practical benefit of society. https://www.icems.kyoto-u.ac.jp/en/

For more information about iCeMS, contact

Izumi Mindy Takamiya [email protected]

Media Contact

Izumi Mindy Takamiya
[email protected]
81-757-539-764
@KyotoU_News

http://www.kyoto-u.ac.jp/en

Share12Tweet8Share2ShareShareShare2

Related Posts

MiRNA Therapies: New Hope Against Heart, Brain Infarctions

October 24, 2025

Microelectrode Arrays Enable Neural Drive Separation in Reinnervated Muscles

October 24, 2025

What Your Eyes Reveal About Aging and Heart Health: Insights from New Research

October 24, 2025

Tackling Medical Imaging Data Gaps with Heterosync

October 24, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1280 shares
    Share 511 Tweet 320
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    309 shares
    Share 124 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    188 shares
    Share 75 Tweet 47
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    133 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Harnessing Microbes to Extract Iron: Transforming Polluted Soils into Self-Cleaning Bio-Reactors

MiRNA Therapies: New Hope Against Heart, Brain Infarctions

Microelectrode Arrays Enable Neural Drive Separation in Reinnervated Muscles

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.